Tom Price bought drug stocks. Then he pushed Pharma’s agenda in Australia.

Tom Price purchased shares worth between $1,000 and $15,000 each in biological drug companies, ProPublica reports.

Continue reading at CNBC - Top News & Analysis →

Comments